Short Summary
Steer Engineering Private Limited (appellant) filed a commercial appeal seeking an interim injunction against Glaxosmithkline Consumer Healthcare (respondents). The appellant claimed infringement of its copyright and trade secrets related to proprietary extrusion technology used for nutritional beverages. The High Court dismissed the appeal, finding that the appellant failed to establish a prima facie case for granting temporary relief.
Detailed Summary
In the high-stakes world of proprietary technology, a company can spend years perfecting a process — only to watch a global competitor allegedly walk away with it. But as Steer Engineering Private Limited discovered, having a legitimate claim is not the same as convincing a court to hit the pause button. This case is a masterclass in why interim injunctions are the hardest relief to win, and why appellate courts rarely second-guess a trial judge's discretion.
Steer Engineering Private Limited, the appellant, is a specialized engineering firm that developed proprietary extrusion technology used in the manufacturing of nutritional beverages. The company claimed that Glaxosmithkline Consumer Healthcare, the respondent and a global consumer healthcare heavyweight, had infringed upon its copyright and misappropriated its trade secrets tied to this extrusion technology. Believing its confidential know-how had been unlawfully accessed or replicated, Steer Engineering approached the court seeking an interim injunction — a temporary order that would freeze GSK's allegedly infringing activities while the underlying dispute was still being decided. When the trial court declined to grant that temporary relief, Steer Engineering escalated the matter by filing a commercial appeal before the High Court.
Steer Engineering argued that its extrusion technology was the product of significant investment, research, and confidential development, and that GSK's use of similar processes amounted to copyright infringement and trade secret misappropriation. The company pushed for an interim injunction on the grounds that allowing GSK to continue its operations during the pendency of the suit would cause irreparable harm to its competitive position and confidential know-how. On the other side, Glaxosmithkline Consumer Healthcare resisted the injunction, and the trial court ultimately sided against Steer Engineering's request for temporary relief. The core legal friction was not about whether infringement had occurred — it was about whether Steer Engineering had done enough, at this preliminary stage, to convince the court that such extraordinary interim relief was warranted.
The High Court dismissed Steer Engineering's commercial appeal, ruling in favor of Glaxosmithkline Consumer Healthcare. The court found that the appellant had failed to establish a prima facie case — the foundational threshold of merit that a party must cross before a court will grant temporary relief. Without that threshold met, there was no legal basis to overturn the trial court's refusal to grant an interim injunction. The appellate court reaffirmed a critical principle: it will not lightly interfere with a trial court's discretionary order on temporary injunctions unless that order is shown to be perverse or illegal. The outcome left Steer Engineering without the immediate protection it sought, while GSK was free to continue its operations pending the resolution of the underlying dispute.
For founders and IP professionals, this case delivers a sobering reminder: interim injunctions are not granted on suspicion or potential — they require a clear, demonstrable prima facie case. If you believe your trade secrets or copyrighted technology have been stolen, do not wait. Delay in filing can undermine your claim to equitable relief, because courts look unfavorably on parties who sit on their rights while the alleged infringer continues to operate. Equally important, understand that appellate courts give wide latitude to trial judges on discretionary matters like temporary injunctions. Your best strategy is to build airtight evidence of ownership, confidentiality, and infringement from day one — so that when you walk into court asking for emergency relief, you are not walking in empty-handed.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before Karnataka High Court. Understanding the court's reasoning in Steer Engineering Private Limited vs Glaxosmithkline Consumer Healthcare Holdings (US)LLC; Glaxosmithkline Consumer Healthcare (UK) IP Limited; Glaxosmithkline Consumer Healthcare (UK) Trading Limited; Smithkline Beecham Limited is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
The North Face Apparel CorpvsController of Patents and Designs
The North Face Apparel Corp challenged the Controller of Patents' refusal of its patent application (No. 202147026139) titled 'Systems and Methods for End-to-End Article Management' before the Madras High Court under Section 117A of the Patents Act, 1970. The Controller had rejected the application citing lack of inventive step over prior art documents D21-D24. The Court held that the Controller erred by dissecting the claims into isolated elements rather than assessing the invention as a whole, and overlooked the use of spectrophotometer and invisible markers for tracking the manufacturing process, which were not disclosed in the cited prior art. The appeal was allowed and the Controller was directed to grant the patent.
Aventose Energy Private LimitedvsThe Assistant Controller of Patents & Designs, Patent Office Chennai
Aventose Energy Private Limited appealed under Section 117A of the Patents Act, 1970 against the refusal of its patent application (No. 202141019671) for a 'System and Method for Operating Automobiles with an Electric Drivetrain' featuring safe mode activation upon fault detection. The Madras High Court found that the Assistant Controller had contradicted the First Examination Report (which accepted novelty) by subsequently holding the invention lacked novelty without giving the applicant an opportunity to be heard. The court further held that the Controller improperly conflated novelty with inventive step under Section 2(1)(ja) and failed to properly analyze the claims against prior art documents D1–D4.
Apex Laboratories Pvt LtdvsElder Lifescience and Ambico Ayurvedic Health Care
Apex Laboratories Pvt Ltd, the prior adopter and registered proprietor of the trademark ZINCOVIT (TM No. 487453 in Class 5) since 1988, sought interim injunction against Elder Lifescience and Ambico Ayurvedic Health Care for using the deceptively similar mark NEO ZINCOVIT. The applicant also claimed copyright infringement of its registered artistic works (A-108878/2014) covering colour scheme, get-up, and layout. The Madras High Court was satisfied that the respondents were attempting to piggyback on the applicant's goodwill and granted interim injunctions on all three applications covering trademark infringement, copyright infringement, and passing off.
Radico Khaitan LimitedvsPicadilly Agro Industries Limited
This Special Leave Petition arose from a judgment dated 29-05-2026 in CS No. 8/2025 passed by the District Judge, Karnal, Haryana, concerning a trademark dispute over the marks 'Cashmere' and 'Kashmyr' used in relation to beer and vodka. The Supreme Court noted that a First Appeal (FAO-COM-11-2026) was already pending before the Division Bench of the Punjab and Haryana High Court, listed for 28.10.2026. The Court disposed of the SLP without adjudicating it on merits, requesting the High Court to pass an appropriate order regarding the ad interim injunction on the scheduled date.
Maharaja Agrasen Technical Educational Society (Regd.)vsMaharaja Agrasen Himalayan Garhwal University
The plaintiff, Maharaja Agrasen Technical Educational Society, filed a suit for permanent injunction against the defendant, Maharaja Agrasen Himalayan Garhwal University, alleging infringement and passing off regarding the use of the words 'Maharaja Agrasen' in the defendant's name. The Delhi High Court had previously granted a restraint order on 10.07.2026. During the pendency of the suit, the parties arrived at a settlement dated 14.09.2026, under which the defendant agreed to change its name through a statutory amendment while being permitted limited transitional use of its existing name. The court recorded the settlement, modified the interim order accordingly, and listed the matter for compliance reporting on 13.07.2027.
Varahi Diamonds And Finance LimitedvsSahil Vinay Mehra Trading As Mehra Sons Jewellers & Anr.
This is a commercial suit filed by Varahi Diamonds And Finance Limited against Sahil Vinay Mehra Trading As Mehra Sons Jewellers & Anr. before the Delhi High Court. The order is primarily procedural, dealing with the registration of the plaint, issuance of summons, directions for filing pleadings, and an interim injunction application. The matter was referred to mediation, with parties directed to appear before the Delhi High Court Mediation and Conciliation Centre.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.